| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Feb―05 |
EQ-5D-5L or EQ-HWB-S: Which is the Better Instrument for Capturing Spillover Effects in Parental Carers of Children with COVID-19? |
Wenjing Zhou, Bo Ding, Jan Busschbach, Michael Herdman, Zhihao Yang, Yanming Lu |
| 2 |
[GO] |
2024―Okt―10 |
The Impact of Tocilizumab Coverage on Health Equity for Inpatients with COVID-19 in the USA: A Distributional Cost-Effectiveness Analysis |
Stacey Kowal, Katherine L. Rosettie |
| 3 |
[GO] |
2024―Jul―03 |
Evaluating the Public Health and Health Economic Impacts of Baloxavir Marboxil and Oseltamivir for Influenza Pandemic Control in China: A Cost-Effectiveness Analysis Using a Linked Dynamic Transmission-Economic Evaluation Model |
Yawen Jiang, Jiaxin Wen, Jiatong Sun, Yuelong Shu |
| 4 |
[GO] |
2024―Mai―10 |
Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review |
Clazinus Veijer, Marinus H. van Hulst, Benjamin Friedrichson, Maarten J. Postma, Antoinette D.I. van Asselt |
| 5 |
[GO] |
2023―Nov―01 |
Cost-Effectiveness Analysis of Vaccines for COVID-19 According to Sex, Comorbidity and Socioeconomic Status: A Population Study |
Javier Mar, Oliver Ibarrondo, Carlo Delfin S. Estadilla, Nico Stollenwerk, Fernando Antoñanzas, Rubén Blasco-Aguado, et al. (+3) Igor Larrañaga, Joseba Bidaurrazaga, Maíra Aguiar |
| 6 |
[GO] |
2023―Jun―21 |
Jumping the Queue:Willingness to Pay for Faster Access to COVID-19 Vaccines in Seven European Countries |
Sebastian Neumann-Böhme, Iryna Sabat, Carolin Brinkmann, Arthur E. Attema, Tom Stargardt, Jonas Schreyögg, Werner Brouwer |
| 7 |
[GO] |
2023―Mrz―27 |
Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US |
Hardik Goswami, Adnan Alsumali, Yiling Jiang, Matthias Schindler, Elizabeth R. Duke, Joshua Cohen, et al. (+2) Andrew Briggs, Amy Puenpatom |
| 8 |
[GO] |
2022―Jul―02 |
Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US |
Hardik Goswami, Adnan Alsumali, Yiling Jiang, Matthias Schindler, Elizabeth R. Duke, Joshua Cohen, et al. (+2) Andrew Briggs, Amy Puenpatom |
| 9 |
[GO] |
2022―Feb―11 |
Correction to: Public Preferences for a COVID-19 Vaccination Program in Q: A Discrete Choice Experiment |
Gabin F. Morillon, Thomas G. Poder |
| 10 |
[GO] |
2022―Jan―20 |
Public Preferences for a COVID-19 Vaccination Program in Q: A Discrete Choice Experiment |
Gabin F. Morillon, Thomas G. Poder |
| 11 |
[GO] |
2021―Okt―12 |
Assessing Technologies for COVID-19: What are the Challenges for Health Technology Assessment Agencies? Findings From a Survey and Roundtable Workshop |
Jamie Elvidge, Dalia Dawoud |
| 12 |
[GO] |
2021―Sep―24 |
Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 Pandemic |
Yumi Asukai, Andrew Briggs, Louis P. Garrison, Benjamin P. Geisler, Peter J. Neumann, Daniel A. Ollendorf |
| 13 |
[GO] |
2021―Sep―02 |
Productivity of Working at Home and Time Allocation Between Paid Work, Unpaid Work and Leisure Activities During a Pandemic |
Samare P. I. Huls, Ayesha Sajjad, Tim A. Kanters, Leona Hakkaart-van Roijen, Werner B. F. Brouwer, Job van Exel |
| 14 |
[GO] |
2021―Jun―19 |
Jointly Modelling Economics and Epidemiology to Support Public Policy Decisions for the COVID-19 Response: A Review of UK Studies |
Ana Duarte, Simon Walker, Andrew Metry, Ruth Wong, Jasmina Panovska-Griffiths, Mark Sculpher |
| 15 |
[GO] |
2021―Jun―17 |
A Net Benefit Approach for the Optimal Allocation of a COVID-19 Vaccine |
Erin Kirwin, Ellen Rafferty, Kate Harback, Jeff Round, Christopher McCabe |
| 16 |
[GO] |
2020―Sep―14 |
On Pandemic Preparedness: How Well is the Modeling Community Prepared for COVID-19? |
Kamal Desai, Eric Druyts, Kevin Yan, Chakrapani Balijepalli |
